VSMD (Vasamed) Cyclically Adjusted PS Ratio: (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vasamed Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Vasamed  (OTCPK:VSMD) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Vasamed Cyclically Adjusted PS Ratio Related Terms


Vasamed Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Vasamed's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vasamed Cyclically Adjusted PS Ratio Chart

Vasamed Annual Data
Trend Dec96 Dec97 Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vasamed Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VSMD vs LENSF, WHSI, ASNB: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Vasamed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vasamed Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vasamed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Vasamed's Cyclically Adjusted PS Ratio falls into.



Vasamed Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Vasamed's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2006 is calculated as:

For example, Vasamed's adjusted Revenue per Share data for the three months ended in Sep. 2006 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2006 (Change)*Current CPI (Sep. 2006)
=0.133/202.9000*202.9000
=0.133

Current CPI (Sep. 2006) = 202.9000.

Vasamed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
199612 0.055 158.600 0.070
199703 0.071 160.000 0.090
199706 0.073 160.300 0.092
199709 0.072 161.200 0.091
199712 0.029 161.300 0.036
199803 0.138 162.200 0.173
199806 0.203 163.000 0.253
199809 0.203 163.600 0.252
199812 0.148 163.900 0.183
199903 0.041 165.000 0.050
199906 0.000 166.200 0.000
199909 0.000 167.900 0.000
199912 0.023 168.300 0.028
200003 0.000 171.200 0.000
200006 0.000 172.400 0.000
200009 0.000 173.700 0.000
200012 0.000 174.000 0.000
200103 0.000 176.200 0.000
200106 0.000 178.000 0.000
200109 0.000 178.300 0.000
200112 0.000 176.700 0.000
200203 0.130 178.800 0.148
200206 0.124 179.900 0.140
200209 0.006 181.000 0.007
200212 0.305 180.900 0.342
200303 0.279 184.200 0.307
200306 0.082 183.700 0.091
200309 0.176 185.200 0.193
200312 0.129 184.300 0.142
200403 0.058 187.400 0.063
200406 0.068 189.700 0.073
200409 0.078 189.900 0.083
200412 0.101 190.300 0.108
200503 0.075 193.300 0.079
200506 0.054 194.500 0.056
200509 0.091 198.800 0.093
200512 0.150 196.800 0.155
200603 0.120 199.800 0.122
200606 0.121 202.900 0.121
200609 0.133 202.900 0.133

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vasamed Business Description

Address 7615 Golden Triangle Drive, Suite A, Eden Prairie, MN, USA, 55344-3733
Vasamed Inc develops, manufactures and markets low-cost, non-invasive peripheral and cardiovascular diagnostic systems for hemodynamic assessment.